Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov(University of Basel), Ken H. Young(Duke Medical Center), Marc Gerhard(University Hospital of Basel), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Nora Gisin(University Hospital of Basel), M. James You, Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Attilio Orazi(Texas Tech University), Carlo Visco(University of Verona), Kristy L. Richards(University of North Carolina at Chapel Hill), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Timothy J. McDonnell(Health Service Executive), Qing Ye(Children's Hospital of Zhejiang University), Andrés JM Ferreri, William W.L. Choi(Chinese University of Hong Kong), L. Jeffrey Medeiros(Delaware Division of Libraries), Stephan Dirnhofer(University of Basel), Jane N. Winter(Northwestern University)
Cited by 129
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k